학술논문

Randomized, open-label, perioperative phase II study evaluating nivolumab alone versus nivolumab plus ipilimumab in patients with resectable HCC
Document Type
Article
Source
In: Annals of oncology : official journal of the European Society for Medical Oncology. (Annals of oncology : official journal of the European Society for Medical Oncology, 1 July 2019, 30:iv112)
Subject
Language
English
ISSN
15698041